Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Accumulated Expenses (2020 - 2025)

Treace Medical Concepts' Accumulated Expenses history spans 6 years, with the latest figure at $1.8 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 72.17% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $1.8 million, down 72.17%, while the annual FY2025 figure was $1.8 million, 72.17% down from the prior year.
  • Accumulated Expenses reached $1.8 million in Q4 2025 per TMCI's latest filing, down from $7.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $13.7 million in Q2 2024 to a low of $1.2 million in Q3 2021.
  • Average Accumulated Expenses over 5 years is $4.9 million, with a median of $4.7 million recorded in 2022.
  • The largest YoY upside for Accumulated Expenses was 357.4% in 2025 against a maximum downside of 88.23% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $1.5 million in 2021, then soared by 308.41% to $6.2 million in 2022, then grew by 21.44% to $7.5 million in 2023, then decreased by 12.9% to $6.6 million in 2024, then tumbled by 72.17% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Accumulated Expenses are $1.8 million (Q4 2025), $7.2 million (Q3 2025), and $1.6 million (Q2 2025).